MORGAN STANLEY - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 14 filers reported holding EVAXION BIOTECH A S in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q3 2023$2,871
-36.4%
3,4460.0%0.00%
Q2 2023$4,514
-89.0%
3,446
-90.5%
0.00%
Q1 2023$40,946
+524.2%
36,235
+880.4%
0.00%
Q4 2022$6,560
-34.4%
3,6960.0%0.00%
Q3 2022$10,000
+25.0%
3,696
-14.0%
0.00%
Q2 2022$8,000
-69.2%
4,296
-48.6%
0.00%
Q1 2022$26,000
+62.5%
8,357
+126.1%
0.00%
Q4 2021$16,000
+700.0%
3,696
+1748.0%
0.00%
Q3 2021$2,000
+100.0%
200
+100.0%
0.00%
Q1 2021$1,0001000.00%
Other shareholders
EVAXION BIOTECH A S shareholders Q4 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 167,500$740,0000.95%
LUMINUS MANAGEMENT LLC 777,990$3,439,0000.81%
Kepos Capital LP 40,000$177,0000.02%
ETF MANAGERS GROUP, LLC 7,000$31,0000.00%
MORGAN STANLEY 3,696$16,0000.00%
Citadel Advisors 140,600$621,0000.00%
Citadel Advisors 13,900$61,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,600$114,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 30,180$134,0000.00%
SIMPLEX TRADING, LLC 400$1,0000.00%
View complete list of EVAXION BIOTECH A S shareholders